Speaker illustration

Mr Pareen Vora

Bayer AG, Berlin (Germany)

Senior Epidemiologist at Bayer Pharmaceuticals. +5 Years experience as an Epidemiologist at Bayer AG +18 months experience in Pharmacovigilance, Clinical Research and Drug Safety My experience includes:- • Leading post-marketing observational studies • Real world evidence, Data generation and Strategic planning • Advanced Data Analytics - OHDSI • Leading Post-Approval Safety Studies (PASS) • Reviewing Protocols & Proposals of the observational studies • Periodic Benefit Risk Evaluation Report (PBRER) and Risk Management Plans (RMP) • Supporting Risk Minimization Activities • Supporting development and life cycle management (LCM) related activities

Long-term adherence to low-dose aspirin therapy for cardiovascular prevention in routine clinical practice in United Kingdom and Germany

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic) ePosters

Thumbnail

Long-term persistence to low-dose aspirin for cardiovascular prevention in routine clinical practice in United Kingdom and Germany

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic) ePosters

Thumbnail

A systematic review of adherence to preventative low-dose aspirin therapy and its effects on ischaemic vascular outcomes

Event: ESC Congress 2018

Topic: Epidemiology

Session: Risk factors and prevention

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb